World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research

Fertility and Sterility

Volumn 102, Issue 5, 2014, Pages 1233-1243

  Rahmioglu, Nilufer ^a   Fassbender, Amelie ^b   Vitonis, Allison F ^c,d   Tworoger, Shelley S ^c,e   Hummelshoj, Lone ^f   D'Hooghe, Thomas M ^b   Adamson, G David ^f,g   Giudice, Linda C ^f,h   Becker, Christian M ^a,i   Zondervan, Krina T ^a,i   Missmer, Stacey A ^c,d,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f World Endometriosis Research Foundation (WERF)   (United Kingdom)

^g PALO ALTO MEDICAL FOUNDATION   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Biological fluid samples; Endometriosis; EPHect; Standard operating procedures; Standardization

Indexed keywords

BLOOD SAMPLING; BLOOD STORAGE; BODY FLUID; CENTRIFUGATION; CONSENSUS; CONSULTATION; ENDOMETRIOSIS; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; LABORATORY; LABORATORY TEST; PERITONEAL FLUID; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ROOM TEMPERATURE; SALIVA; SALIVA ANALYSIS; SERUM; STANDARD; TEAMWORK; URINALYSIS; URINE; UTERUS FLUID; WORKSHOP; BLOOD; HEALTH CARE FACILITY; INTERNATIONAL COOPERATION; LABORATORY DIAGNOSIS; PATHOLOGY; STANDARDS;

BLOOD SPECIMEN COLLECTION; ENDOMETRIOSIS; FEMALE; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; SPECIMEN HANDLING; TISSUE BANKS;

EID: 84922064610     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.07.1208     Document Type: Review

References (76)

1. Rogers PA, D'Hooghe TM, Fazleabas A, Giudice LC, Montgomery GW, Petraglia F, et al. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France. Reprod Sci 2013;20:483-99.
2. Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncology 2010;28:698-704.
3. Tworoger SS, Hankinson SE. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 2006;17:889-99.
4. Sheldon E, Vo KC, McIntire RA, Aghajanova L, Zelenko Z, Irwin JC, et al. Biobanking human endometrial tissue and blood specimens: standard operating procedure and importance to reproductive biology research and diagnostic development. Fertil Steril 2011;95:2120-2.e12.
5. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril 2013;99:1135-45.
6. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genet 2013;45:371-84.
7. Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Australian Cancer S, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genet 2014;133:481-97.
8. Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 2012;104:1905-16.
9. Endogenous Hormones and Breast Cancer Collaborative Group, GKey TJ, Appleby PN, Reeves GK, Travis RC, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013;14:1009-19.
10. Mitta VP, Christen WG, Glynn RJ, Semba RD, Ridker PM, Rimm EB, et al. Creactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. JAMA Ophthal 2013;131:507-13.
11. Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, Capurso G, et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013;29:1637-44.
12. Rudolph A, Hein R, Lindstrom S, Beckmann L, Behrens S, Liu J, et al. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocrine-related Cancer 2013;20:875-87.
13. Moore HM. The NCI Biospecimen Research Network. Biotechnic Histochem 2012;87:18-23.
14. Vaught J, Lockhart NC. The evolution of biobanking best practices. Clin Chim Acta 2012;413:1569-75.
15. Yuille M, van Ommen GJ, Brechot C, Cambon-Thomsen A, Dagher G, Landegren U, et al. Biobanking for Europe. Briefings Bioinformatics 2008;9:14-24.
16. Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. New Engl J Med 2012;366:234-42.
17. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, Wiegand KC, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. New EnglJ Med 2009;360:2719-29.
18. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. New Engl J Med 2010;363:1532-43.
19. Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, et al. Priorities for endometriosis research: recommendations fromaninternational consensusworkshop. Reprod Sci 2009;16:335-46.
20. Becker CM, Stratton P, Hummelshoj L, Missmer SM, Zondervan KT, Missmer SA. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research. Fertil Steril 2014;102:1213-22.
21. Vitonis AF, Rahmioglu N, Fassbender A, Buck Louis GM, Hummelshoj L, Giudice LC, et al. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril 2014;102:1223-32.
22. Fassbender A, Rahmioglu N, Vitonis AF, Vigano P, Giudice LC, D'Hooghe TM, Hummelshoj L, et al. WERF Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research. Fertil Steril 2014;102:1244-53.
23. Peplies J, Gunther K, Bammann K, Fraterman A, Russo P, Veidebaum T, et al. Influence of sample collection and preanalytical sample processing on the analyses of biological markers in the European multicentre study IDEFICS. Int J Obesity 2011;35(Suppl 1):104-12.
24. Thorpe JD, Duan X, Forrest R, Lowe K, Brown L, Segal E, et al. Effects of blood collection conditions on ovarian cancer serum markers. PloS One 2007;2:e1281.
25. Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, De Palo EF. Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 2009;42:1205-17.
26. Elliott P, Peakman TC, Biobank UK. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008;37:234-44.
27. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000;12:1712-6.
28. Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutation Res 2003;543:217-34.
29. Palmer-Toy DE, Szczepiorkowski ZM, Shih V, Van Cott EM. Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood. Clin Chem 2001;47:1704-7.
30. Kyama CM, Overbergh L, Debrock S, Valckx D, Vander Perre S, Meuleman C, et al. Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril 2006;85:1667-75.
31. Kyama CM, Overbergh L, Mihalyi A, Meuleman C, Mwenda JM, Mathieu C, et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 2008;89:301-10.
32. Kyama CM, T'Jampens D, Mihalyi A, Simsa P, Debrock S, Waelkens E, et al. ProteinChip technology is a useful method in the pathogenesis and diagnosis of endometriosis: a preliminary study. Fertil Steril 2006;86:203-9.
33. Tomassetti C, Meuleman C, Pexsters A, Mihalyi A, Kyama C, Simsa P, et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online 2006;13:58-64.
34. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005;5:3262-77.
35. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, et al. Peptidomic analysis ofhuman blood specimens: comparison between plasma specimens and serumby differential peptide display. Proteomics 2005;5:3414-22.
36. Peakman TC, Elliott P. The UK Biobank sample handling and storage validation studies. Int J Epidemiol 2008;37(Suppl 1):i2-6.
37. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 2011;49:231-43.
38. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009;8:113-7.
39. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
40. Townsend MK, Clish CB, Kraft P, Wu C, Souza AL, Deik AA, et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem 2013;59:1657-67.
41. Holland NT, Pfleger L, Berger E, Ho A, Bastaki M. Molecular epidemiology biomarkers - sample collection and processing considerations. Toxicol Appl Pharmacol 2005;206:261-8.
42. Grizzle WE, Semmes OJ, Bigbee W, Zhu L, Malik G, Oelschlager DK, et al. The need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis. Cancer Informatics 2005;1:86-97.
43. Su SC, Garbers S, Rieper TD, Toniolo P. Temperature variations in upright mechanical freezers. Cancer Epidemiol Biomarkers Prevention 1996;5:139-40.
44. Mallick P, Kuster B. Proteomics: a pragmatic perspective. Nature Biotechnol 2010;28:695-709.
45. Silberring J, Ciborowski P. Biomarker discovery and clinical proteomics. Trends Analytic Chem 2010;29:128.
46. Hankinson SE, Tworoger SS. Assessment of the Hormonal Milieu. In: Rothman N, Hainaut P, Schulte P, Smith M, Boffetta P, Perera F, editors. Molecular epidemiology: principles and practices, Vol. 163. IARC Scientific Publication, Lyon, France; 2012.
47. Saude EJ, Adamko D, Rowe BH, Marrie T, Sykes BD. Variation of metabolites in normal human urine. Metabolomics 2007;3:439-51.
48. Koni AC, Scott RA, Wang G, Bailey ME, Peplies J, Bammann K, et al. DNA yield and quality of saliva samples and suitability for large-scale epidemiological studies in children. Int J Obesity 2011;35(Suppl 1):113-8.
49. Abraham JE, Maranian MJ, Spiteri I, Russell R, Ingle S, Luccarini C, et al. Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping. BMC Med Genomics 2012;5:19.
50. Shirtcliff EA, Granger DA, Schwartz E, Curran MJ. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001;26:165-73.
51. Hansen TV, Simonsen MK, Nielsen FC, Hundrup YA. Collection of blood, saliva, and buccal cell samples in a pilot study on the Danish nurse cohort: comparison of the response rate and quality of genomic DNA. Cancer Epidemiol Biomarkers Prev 2007;16:2072-6.
52. Livy A, Lye S, Jagdish CK, Hanis N, Sharmila V, Ler LW, et al. Evaluation of quality of DNA extracted from buccal swabs for microarray based genotyping. Indian J Clin Biochem 2012;27:28-33.
53. Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR. Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect 1999;107:517-20.
54. Mohamed R, Campbell JL, Cooper-White J, Dimeski G, Punyadeera C. The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassays. Clin Trans Med 2012;1:19.
55. Navazesh M, Kumar SK. University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dental Assoc 2008;139(Suppl):35S-40S.
56. Pulford DJ, Mosteller M, Briley JD, Johansson KW, Nelsen AJ. Saliva sampling in global clinical studies: the impact of low sampling volume on performance of DNA in downstream genotyping experiments. BMC Med Genomics 2013;6:20.
57. Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007;383:30-40.
58. Rockett JC, Buck GM, Lynch CD, Perreault SD. The value of home-based collection of biospecimens in reproductive epidemiology. Environ Health Perspect 2004;112:94-104.
59. Kalu E, Sumar N, Giannopoulos T, Patel P, Croucher C, Sherriff E, et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gyn Res 2007;33:490-5.
60. Koninckx PR, Kennedy SH, Barlow DH. Pathogenesis of endometriosis: the role of peritoneal fluid. Gynecol Obstet Investigation 1999;47(Suppl 1):23-33.
61. Pupo-Nogueira A, de Oliveira RM, Petta CA, Podgaec S, Dias JA Jr, Abrao MS. Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis. Int J Gyn Obstet 2007;99:33-7.
62. Ametzazurra A, Matorras R, Garcia-Velasco JA, Prieto B, Simon L, Martinez A, et al. Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis. Human Reprod 2009;24:954-65.
63. Casado-Vela J, Rodriguez-Suarez E, Iloro I, Ametzazurra A, Alkorta N, Garcia-Velasco JA, et al. Comprehensive proteomic analysis of human endometrial fluid aspirate. J Proteome Res 2009;8:4622-32.
64. Malik S, Day K, Perrault I, Charnock-Jones DS, Smith SK. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia. Human Reprod 2006;21:2158-66.
65. Scotchie JG, Fritz MA, Mocanu M, Lessey BA, Young SL. Proteomic analysis of the luteal endometrial secretome. Reprod Sci 2009;16:883-93.
66. Hannan NJ, Nie G, Rainzcuk A, Rombauts LJ, Salamonsen LA. Uterine lavage or aspirate: which view of the intrauterine environment? Reprod Sci 2012;19:1125-32.
67. Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci 2011;18:229-51.
68. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007;148:3814-26.
69. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003;144:2870-81.
70. Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006;147:1097-121.
71. Fassbender A, Verbeeck N, Bornigen D, Kyama CM, Bokor A, Vodolazkaia A, et al. Combined mRNA microarray and proteomic analysis of eutopic endometrium of women with and without endometriosis. Human Reprod 2012; 27:2020-9.
72. Baird DD, McConnaughey DR, Weinberg CR, Musey PI, Collins DC, Kesner JS, et al. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology 1995;6:547-50.
73. Waller K, Swan SH, Windham GC, Fenster L, Elkin EP, Lasley BL. Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women. Am J Epidemiology 1998;147:1071-80.
74. Shah DK, Correia KF, Vitonis AF, Missmer SA. Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort. Human Reprod 2013;28:1783-92.
75. CDC. National Health and Nutrition Examination Survey III: Body Measurements (Anthropometry). Centers for Disease Control, Rockville, Maryland, USA; 1988.
76. McDowell MA, Fryar CD, Ogden CL. Anthropometric reference data for children and adults: United States, 1988-1994. Vital and health statistics Series 11, Data from the national health survey, Hyattsville, Maryland; 2009:1-68.